entity:mercury_prep_n_batch_id	amplicon_primer_scheme	amplicon_size	assembly_fasta	assembly_length_unambiguous	assembly_mean_coverage	assembly_method	authors	bioproject_accession	collecting_lab	collecting_lab_address	collection_date	continent	country	county	gisaid_submitter	host_disease	instrument_model	isolation_source	library_id	library_layout	library_selection	library_source	library_strategy	nextclade_aa_dels	nextclade_aa_subs	nextclade_clade	number_N	number_Total	organism	pango_lineage	pangolin_assignment_version	pangolin_docker	pangolin_notes	pangolin_versions	patient_age	patient_gender	percent_reference_coverage	purpose_of_sampling	purpose_of_sequencing	read1_dehosted	read2_dehosted	run_id	seq_platform	sequencing_protocol_name	state	submission_id	submitter_email	submitting_lab	submitting_lab_address	vadr_docker	vadr_num_alerts
sample01	Artic V3	400	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/assemblies/SARS-CoV-2_human_AUS_TL26_2020.ivar.consensus.fasta	28376	3762.16	PHVG v1.5.2	Kevin Libuit	PRJN0001	Theiagen Genomics	ABC 123 Street	2021-09-06	North America	USA	King	libuitkg	COVID-19	GridION	Clinical	WA-TGN-_Sample_01_01	paired	PCR	VIRAL RNA	AMPLICON		N:S194L,ORF1b:P314L,ORF1b:M1359V,S:L54F,S:D614G	20A	1489	29865	SARS-CoV-2	B.1.240	pangolin 3.1.11; PUSHER-v1.2.66	staphb/pangolin:3.1.11-pangolearn-2021-08-24	Usher placements: B.1.240(1/1)	pangolin: 3.1.11;pangolearn: 2021-08-24;constellations: v0.0.15;scorpio: 0.3.12;pango-designation: 1.2.73;UShER (v0.4.6)		Male	94.89	clinical diagnostics	Baseline surveillance	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/SARS-CoV-2_human_AUS_TL26_2020_1.fastq.gz	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/SARS-CoV-2_human_AUS_TL26_2020_2.fastq.gz	ONT_2021-09-08	OXFORD_NANOPORE	Artic V3	Washington	WA-TGN-00001	Kevin.Libuit@theiagen.com	Theiagen Genomics	ABC 123 Street	staphb/vadr:1.3	0
sample02	Artic V3	400	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/assemblies/hCoV-19_USA_CA-QDX-2781_2020.ivar.consensus.fasta	29858	3375.51	PHVG v1.5.2	Kevin Libuit	PRJN0001	Theiagen Genomics	ABC 123 Street	2021-09-06	North America	USA		libuitkg	COVID-19	GridION	Clinical	WA-TGN-_Sample_02_01	paired	PCR	VIRAL RNA	AMPLICON		N:S194L,ORF1a:V306F,ORF1a:A668V,ORF1a:P3359L,ORF1a:V3892I,ORF1b:P314L,ORF1b:A2168T,S:D614G,S:A892S	20A	43	29901	SARS-CoV-2	B.1.400	pangolin 3.1.11; PUSHER-v1.2.66	staphb/pangolin:3.1.11-pangolearn-2021-08-24	Usher placements: B.1.400(1/1)	pangolin: 3.1.11;pangolearn: 2021-08-24;constellations: v0.0.15;scorpio: 0.3.12;pango-designation: 1.2.73;UShER (v0.4.6)		Male	99.85		Baseline surveillance	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_CA-QDX-2781_2020_1.fastq.gz	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_CA-QDX-2781_2020_2.fastq.gz	ONT_2021-09-08	OXFORD_NANOPORE	Artic V3	Washington	WA-TGN-00002	Kevin.Libuit@theiagen.com	Theiagen Genomics	ABC 123 Street	staphb/vadr:1.3	0
sample03	Artic V3	400	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/assemblies/hCoV-19_USA_CO-CDPHE-2004220748_2020.ivar.consensus.fasta	29860	17193.5	PHVG v1.5.2	Kevin Libuit	PRJN0001	Theiagen Genomics	ABC 123 Street	2021-09-06	North America	USA		libuitkg	COVID-19	GridION	Clinical	WA-TGN-_Sample_03_01	paired	PCR	VIRAL RNA	AMPLICON		N:P67S,N:P199L,ORF1a:T265I,ORF1a:L642F,ORF1a:M2606I,ORF1a:L3352F,ORF1b:P314L,ORF1b:M1197I,ORF1b:N1653D,ORF1b:R2613C,ORF3a:Q57H,ORF3a:G172V,ORF3a:P240S,ORF8:S24L,S:D614G,S:T719I	20G	43	29903	SARS-CoV-2	B.1.2	pangolin 3.1.11; PUSHER-v1.2.66	staphb/pangolin:3.1.11-pangolearn-2021-08-24	Usher placements: B.1.2(1/1)	pangolin: 3.1.11;pangolearn: 2021-08-24;constellations: v0.0.15;scorpio: 0.3.12;pango-designation: 1.2.73;UShER (v0.4.6)	25	Female	99.86	clinical diagnostics	Targeted surveillance	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_CO-CDPHE-2004220748_2020_1.fastq.gz	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_CO-CDPHE-2004220748_2020_2.fastq.gz	ONT_2021-09-08	OXFORD_NANOPORE	Artic V3	Washington	WA-TGN-00003	Kevin.Libuit@theiagen.com	Theiagen Genomics	ABC 123 Street	staphb/vadr:1.3	0
sample04	Artic V3	400	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/assemblies/hCoV-19_USA_CO-CDPHE-2007251462_2020.ivar.consensus.fasta	29893	9620.59	PHVG v1.5.2	Kevin Libuit	PRJN0001	Theiagen Genomics	ABC 123 Street	2021-09-06	North America	USA		libuitkg	COVID-19	GridION	Clinical	WA-TGN-_Sample_04_01	paired	PCR	VIRAL RNA	AMPLICON		N:S235F,ORF1a:D144A,ORF1a:H388Y,ORF1a:K1202N,ORF1a:T2007I,ORF1b:P314L,ORF1b:L605F,ORF1b:P2321L,S:A243S,S:E583Q,S:D614G	20A	10	29903	SARS-CoV-2	B.1.565	pangolin 3.1.11; PANGO-v1.2.66	staphb/pangolin:3.1.11-pangolearn-2021-08-24	Assigned from designation hash.	pangolin: 3.1.11;pangolearn: 2021-08-24;constellations: v0.0.15;scorpio: 0.3.12;pango-designation: 1.2.73;UShER (v0.4.6)	62	Female	99.97			gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_CO-CDPHE-2007251462_2020_1.fastq.gz	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_CO-CDPHE-2007251462_2020_2.fastq.gz	ONT_2021-09-08	OXFORD_NANOPORE	Artic V3	Washington	WA-TGN-00004	Kevin.Libuit@theiagen.com	Theiagen Genomics	ABC 123 Street	staphb/vadr:1.3	0
sample05	Artic V3	400	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/assemblies/hCoV-19_USA_CT-QDX-2695_2020.ivar.consensus.fasta	29899	15084.3	PHVG v1.5.2	Kevin Libuit	PRJN0001	Theiagen Genomics	ABC 123 Street	2021-09-06	North America	USA	Clark	libuitkg	COVID-19	GridION	Clinical	WA-TGN-_Sample_05_01	paired	PCR	VIRAL RNA	AMPLICON		N:S194L,ORF1a:F190L,ORF1a:T265I,ORF1a:G519S,ORF1a:E1196D,ORF1b:P314L,ORF1b:L629F,ORF1b:P2313L,ORF3a:Q57H,ORF3a:G100C,ORF3a:V259L,ORF8:S24L,S:D614G	20C	4	29903	SARS-CoV-2	B.1	pangolin 3.1.11; PANGO-v1.2.66	staphb/pangolin:3.1.11-pangolearn-2021-08-24	Assigned from designation hash.	pangolin: 3.1.11;pangolearn: 2021-08-24;constellations: v0.0.15;scorpio: 0.3.12;pango-designation: 1.2.73;UShER (v0.4.6)		Male	99.99			gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_CT-QDX-2695_2020_1.fastq.gz	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_CT-QDX-2695_2020_2.fastq.gz	ONT_2021-09-08	OXFORD_NANOPORE	Artic V3	Washington	WA-TGN-00005	Kevin.Libuit@theiagen.com	Theiagen Genomics	ABC 123 Street	staphb/vadr:1.3	0
sample06	Artic V3	400	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/assemblies/hCoV-19_USA_MA-MGH-01206_2020.ivar.consensus.fasta	29823	8819.23	PHVG v1.5.2	Kevin Libuit	PRJN0001	Theiagen Genomics	ABC 123 Street	2021-09-06	North America	USA	King	libuitkg	COVID-19	GridION	Clinical	WA-TGN-_Sample_06_01	paired	PCR	VIRAL RNA	AMPLICON		N:P67S,N:P199L,ORF1a:T265I,ORF1a:L642F,ORF1a:M2606I,ORF1a:L3352F,ORF1b:P314L,ORF1b:M1197I,ORF1b:N1653D,ORF1b:R2613C,ORF3a:Q57H,ORF3a:G172V,ORF3a:T175I,ORF3a:P240S,ORF8:S24L,S:D614G	20G	80	29903	SARS-CoV-2	B.1.2	pangolin 3.1.11; PUSHER-v1.2.66	staphb/pangolin:3.1.11-pangolearn-2021-08-24	Usher placements: B.1.2(1/1)	pangolin: 3.1.11;pangolearn: 2021-08-24;constellations: v0.0.15;scorpio: 0.3.12;pango-designation: 1.2.73;UShER (v0.4.6)		Male	99.73			gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_MA-MGH-01206_2020_1.fastq.gz	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_MA-MGH-01206_2020_2.fastq.gz	ONT_2021-09-08	OXFORD_NANOPORE	Artic V3	Washington	WA-TGN-00006	Kevin.Libuit@theiagen.com	Theiagen Genomics	ABC 123 Street	staphb/vadr:1.3	0
sample07	Artic V3	400	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/assemblies/hCoV-19_USA_MA-MGH-02728_2020.ivar.consensus.fasta	29519	14139.2	PHVG v1.5.2	Kevin Libuit	PRJN0001	Theiagen Genomics	ABC 123 Street	2021-09-06	North America	USA	Clark	libuitkg	COVID-19	GridION	Clinical	WA-TGN-_Sample_07_01	paired	PCR	VIRAL RNA	AMPLICON		N:P67S,N:P199L,N:T247I,N:Q389L,ORF1a:T265I,ORF1a:L3352F,ORF1b:P314L,ORF1b:V767L,ORF1b:N1653D,ORF1b:V1691L,ORF1b:R2613C,ORF3a:Q57H,ORF3a:G172V,ORF3a:S180P,ORF7b:S5L,ORF8:S24L,S:D614G	20G	367	29886	SARS-CoV-2	B.1.2	pangolin 3.1.11; PUSHER-v1.2.66	staphb/pangolin:3.1.11-pangolearn-2021-08-24	Usher placements: B.1.2(1/1)	pangolin: 3.1.11;pangolearn: 2021-08-24;constellations: v0.0.15;scorpio: 0.3.12;pango-designation: 1.2.73;UShER (v0.4.6)			98.72	clinical diagnostics	Targeted surveillance	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_MA-MGH-02728_2020_1.fastq.gz	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_MA-MGH-02728_2020_2.fastq.gz	ONT_2021-09-08	OXFORD_NANOPORE	Artic V3	Washington	WA-TGN-00007	Kevin.Libuit@theiagen.com	Theiagen Genomics	ABC 123 Street	staphb/vadr:1.3	0
sample08	Artic V3	400	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/assemblies/hCoV-19_USA_MA-MGH-03162_2020.ivar.consensus.fasta	29486	20815.8	PHVG v1.5.2	Kevin Libuit	PRJN0001	Theiagen Genomics	ABC 123 Street	2021-09-06	North America	USA		libuitkg	COVID-19	GridION	Clinical	WA-TGN-_Sample_08_01	paired	PCR	VIRAL RNA	AMPLICON		N:P67S,N:P199L,N:Q389L,ORF1a:T265I,ORF1a:L3352F,ORF1b:P314L,ORF1b:V767L,ORF1b:N1653D,ORF1b:V1691L,ORF1b:R2613C,ORF3a:Q57H,ORF3a:G172V,ORF3a:S180P,ORF7b:S5L,ORF8:S24L,S:D614G,S:V615F	20G	338	29825	SARS-CoV-2	B.1.2	pangolin 3.1.11; PUSHER-v1.2.66	staphb/pangolin:3.1.11-pangolearn-2021-08-24	Usher placements: B.1.2(1/1)	pangolin: 3.1.11;pangolearn: 2021-08-24;constellations: v0.0.15;scorpio: 0.3.12;pango-designation: 1.2.73;UShER (v0.4.6)			98.61	clinical diagnostics	Targeted surveillance	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_MA-MGH-03162_2020_1.fastq.gz	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_MA-MGH-03162_2020_2.fastq.gz	ONT_2021-09-08	OXFORD_NANOPORE	Artic V3	Washington	WA-TGN-00008	Kevin.Libuit@theiagen.com	Theiagen Genomics	ABC 123 Street	staphb/vadr:1.3	0
sample09	Artic V3	400	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/assemblies/hCoV-19_USA_MA-QDX-2966_2021.ivar.consensus.fasta	29175	10023.7	PHVG v1.5.2	Kevin Libuit	PRJN0001	Theiagen Genomics	ABC 123 Street	2021-09-06	North America	USA		libuitkg	COVID-19	GridION	Clinical	WA-TGN-_Sample_09_01	paired	PCR	VIRAL RNA	AMPLICON		N:P67S,N:P199L,N:T247I,N:Q389L,ORF1a:T265I,ORF1a:L3352F,ORF1b:P314L,ORF1b:V767L,ORF1b:N1653D,ORF1b:V1691L,ORF1b:R2613C,ORF3a:Q57H,ORF3a:G172V,ORF3a:S180P,ORF8:S24L,S:D614G	20G	631	29806	SARS-CoV-2	B.1.2	pangolin 3.1.11; PUSHER-v1.2.66	staphb/pangolin:3.1.11-pangolearn-2021-08-24	Usher placements: B.1.2(1/1)	pangolin: 3.1.11;pangolearn: 2021-08-24;constellations: v0.0.15;scorpio: 0.3.12;pango-designation: 1.2.73;UShER (v0.4.6)		Male	97.57			gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_MA-QDX-2966_2021_1.fastq.gz	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_MA-QDX-2966_2021_2.fastq.gz	ONT_2021-09-08	OXFORD_NANOPORE	Artic V3	Washington	WA-TGN-00009	Kevin.Libuit@theiagen.com	Theiagen Genomics	ABC 123 Street	staphb/vadr:1.3	1
sample10	Artic V3	400	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/assemblies/hCoV-19_USA_MN-QDX-1320_2020.ivar.consensus.fasta	29002	4233.37	PHVG v1.5.2	Kevin Libuit	PRJN0001	Theiagen Genomics	ABC 123 Street	2021-09-06	North America	USA		libuitkg	COVID-19	GridION	Clinical	WA-TGN-_Sample_10_01	paired	PCR	VIRAL RNA	AMPLICON		N:P67S,N:P199L,N:T247I,N:Q389L,ORF1a:T265I,ORF1a:L3352F,ORF1b:P314L,ORF1b:V767L,ORF1b:N1653D,ORF1b:V1691L,ORF3a:Q57H,ORF3a:G172V,ORF3a:S180P,ORF8:S24L,S:D614G	20G	868	29870	SARS-CoV-2	B.1.2	pangolin 3.1.11; PUSHER-v1.2.66	staphb/pangolin:3.1.11-pangolearn-2021-08-24	Usher placements: B.1.2(1/1)	pangolin: 3.1.11;pangolearn: 2021-08-24;constellations: v0.0.15;scorpio: 0.3.12;pango-designation: 1.2.73;UShER (v0.4.6)	35	Male	96.99	clinical diagnostics		gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_MN-QDX-1320_2020_1.fastq.gz	gs://theiagen-public-resources-rp/validation_datasets/phb_validation/theiacov/sars-cov-2/illumina/hCoV-19_USA_MN-QDX-1320_2020_2.fastq.gz	ONT_2021-09-08	OXFORD_NANOPORE	Artic V3	Washington	WA-TGN-00010	Kevin.Libuit@theiagen.com	Theiagen Genomics	ABC 123 Street	staphb/vadr:1.3	0
